NDA 19465, held by Hospira. Sodium Chloride.
As of Nov 13, 2026, NDA 19465 (Sodium Chloride 0.9% In Plastic Container), held by Hospira, was first approved by FDA on Jul 15, 1985, with 35 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Intravenous solutions containing sodium chloride are indicated for parenteral replenishment of fluid and sodium chloride as required by the clinical condition of the patient. In this dosage form, Sodium Chloride Injection, USP is intended to be used as a diluent for the contents of an ADD-Vantage vial, or single-dose vials with 20 mm closure using the ADD-Vantage ADDAPTOR.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 1985 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Sodium Chloride 0.9% In Plastic Container900MG/100ML · solution;injection | Sodium Chloride | RxReference drug |
| Sodium Chloride 0.9% In Plastic Container450MG/50ML (9MG/ML) · solution;injection | Sodium Chloride | RxReference drug |
| May 29, 2019 | Supplement 58Manufacturing | Approved | None posted |
| Sep 27, 2016 | Supplement 55Labeling · Standard review | Approved | |
| Jun 10, 2016 | Supplement 54Labeling · Standard review | Approved | |
| Nov 1, 2002 | Supplement 38Manufacturing · Standard review | Approved | None posted |
| Apr 6, 2000 | Supplement 37Manufacturing · Standard review | Approved | None posted |
| Apr 6, 2000 | Supplement 36Labeling | Approved | None posted |
| Apr 6, 2000 | Supplement 35Manufacturing · Standard review | Approved | None posted |
| Jul 2, 1999 | Supplement 31Labeling | Approved | None posted |
| Dec 1, 1998 | Supplement 34Manufacturing · Standard review | Approved | None posted |
| Aug 20, 1997 | Supplement 33Manufacturing · Standard review | Approved | None posted |
| Jun 11, 1997 | Supplement 32Manufacturing · Standard review | Approved | None posted |
| Aug 27, 1996 | Supplement 28Manufacturing · Standard review | Approved | None posted |
| Mar 4, 1996 | Supplement 30Manufacturing · Standard review | Approved | None posted |
| Jan 24, 1996 | Supplement 27Manufacturing · Standard review | Approved | None posted |
| May 31, 1995 | Supplement 29Manufacturing · Standard review | Approved | None posted |
| Jan 5, 1995 | Supplement 25Manufacturing · Standard review | Approved | None posted |
| Sep 23, 1994 | Supplement 26Manufacturing · Standard review | Approved | None posted |
| Jun 21, 1994 | Supplement 24Labeling | Approved | None posted |
| Feb 25, 1994 | Supplement 23Manufacturing · Standard review | Approved | None posted |
| Feb 16, 1993 | Supplement 15Labeling | Approved | None posted |
| Jan 28, 1992 | Supplement 17Manufacturing · Standard review | Approved | None posted |
| Dec 30, 1991 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Sep 10, 1991 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Nov 2, 1990 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| Mar 9, 1990 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Feb 22, 1990 | Supplement 11Manufacturing · Standard review | Approved | None posted |
| Jan 11, 1990 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Sep 20, 1989 | Supplement 8Labeling | Approved | None posted |
| Aug 3, 1989 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Jul 18, 1989 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Feb 6, 1989 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| Nov 26, 1986 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Aug 8, 1986 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| May 27, 1986 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Jan 17, 1986 | Supplement 1Labeling | Approved | None posted |
| Jul 15, 1985 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters